JAMA Otolaryngology Head & Neck Surgery, 131 (11), 970-975
Our BPC-157 10mg pen is supplied exclusively for laboratory research and analytical testing
Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction
BPC-157, also known as Body Protection Compound 157, is a synthetic peptide consisting of 15 amino acids, making it a pentadecapeptide
Key applications include: Cosmetic Anti-Aging Programs: In aesthetic clinics, GHK-Cu is often one part of a facial rejuvenation protocol
Stimulation of Angiogenesis and Microcirculation : Research indicates that BPC-157 promotes angiogenesis by upregulating the expression of vascular endothelial growth factor (VEGF) and FAK-paxillin signaling in fibroblasts